


FightingBack
44.3K posts

@FightingbackHD
Stock Market Investor & Swing trader.. Technical's and Fundamentals.... NO chatroom - NO Discord - NO Products to sell Not Investment Advice - My Opinions




$IXHL announces that participant screening has commenced in the Company’s DReAMzz Phase 2 dose confirmation study evaluating IHL-42X for the treatment of obstructive sleep apnea (“OSA”). The commencement of screening represents the transition of the DReAMzz study into active clinical recruitment and follows significant operational progress made by the Company. Full press release here: ir.incannex.com/news-releases/…













$IXHL announces that participant screening has commenced in the Company’s DReAMzz Phase 2 dose confirmation study evaluating IHL-42X for the treatment of obstructive sleep apnea (“OSA”). The commencement of screening represents the transition of the DReAMzz study into active clinical recruitment and follows significant operational progress made by the Company. Full press release here: ir.incannex.com/news-releases/…